$CXM

Sprinklr, Inc. (CXM): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Sprinklr, Inc. (CXM) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K false 0001569345 0001569345 2026-08-10 2026-08-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10

Original reporting
Published Aug 13, 2026, 11:37 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 12:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$CXM
Neutral
medium confidence
Mentioned
$CXM
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CXMNeutralLow
01

Why it matters

The main tradable content is the governance change: board size increases to eight, Jordi Ribas joins as a Class II director, and Eileen Schloss is removed from the Strategy Committee effective Aug 17, 2026. Compensation details are disclosed, but there is no financial forecast or operational update.

02

Market read

This is a governance and compensation disclosure with limited direct implications for near-term earnings or cash flows.

03

What to watch

Traders may overreact to the Microsoft background; the filing does not state new initiatives, budgets, or customer wins tied to the director appointment.

Relevance 6/10Novelty 4/10Timing: filed Aug 13, 2026, effective Aug 17, 2026

Background

Sprinklr filed an SEC Form 8-K under Item 5.02 describing a director appointment, committee assignments, and related non-employee director compensation.

Company-level read

Ticker impact

$CXMNeutralMedium confidence
Context

Sprinklr appointed Jordi Ribas to its board and strategy committee, with disclosed RSU and cash compensation terms in an 8-K.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven rather than fundamentals.

Evidence & confidence

The filing is a governance/compensation disclosure (Item 5.02) with specific pay amounts and committee membership changes, without earnings, guidance, contracts, or regulatory outcomes.

Market effects

Minimal, as this is company-specific governance and compensation rather than a sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

The appointment could be interpreted as a strategic push toward AI/search capabilities, but the 8-K does not quantify any resulting product or revenue impact.

Key entities

  • Sprinklr, Inc.

    Company filing the 8-K; increased board size and appointed Jordi Ribas to the board and Strategy Committee.

  • Jordi Ribas, Ph.D.

    Appointed Class II director effective Aug 17, 2026; serves on Nom Gov and Strategy committees; compensation terms disclosed.

  • Eileen Schloss

    Removed from the Strategy Committee effective Aug 17, 2026 in connection with Ribas’s appointment.

  • Microsoft Corporation

    Ribas’s current employer at the time of appointment; referenced for his AI/search background.

Related articles

$CXMMedAI 8/10

Sprinklr (CXM) Reports Q1 EPS

Sprinklr (NYSE:CXM) reported Q1 EPS of 11 cents, above the 10-cent consensus, and revenue of $219.5M, ahead of the $215.91M estimate, according to the company. For FY27, it forecast EPS of 48–49 cents (vs. 48 cents expected) and revenue of $866.5M–$868.5M (vs. $870.63M). The firm also said it acquired ViralMoment’s AI video analytics assets.

$CXMMedAI 9/10

Sprinklr (CXM) Q4 2026 Earnings Transcript

Sprinklr reported Q4 FY2026 revenue of $220.6M (+9% YoY) and subscription revenue of $193.4M (+6%). Non-GAAP operating income was $37.7M (17% margin) and free cash flow $15.9M. Renewal rates were the highest of FY2026; RPO was $986.5M. Q1 guidance: revenue $215.5M–$216.5M; FY2027 revenue $869M–$871M. A $200M share buyback was authorized.

$CXMMedAI 9/10

Earnings To Watch: Sprinklr (CXM) Reports Q1 Results Tomorrow

Sprinklr (NYSE:CXM) is set to report Q1 earnings Wednesday before market open, according to the article. The company’s prior quarter revenue was $220.6 million, up 8.9% year over year. Analysts expect this quarter’s revenue to rise 5.1% year over year. The article cites an average analyst price target of $8.47 versus a $5.99 share price.

$BHVNHighAI 9/10

Biohaven And SK Biopharmaceuticals Enter Strategic Global Licensing Agreement; Stock Up

Biohaven (BHVN) and SK Biopharmaceuticals agreed to a global licensing deal for Biohaven's Kv7 ion channel platform, including Opakalim (BHV-7000) for epilepsy. SK Biopharmaceuticals will pay up to $795M in upfront and milestone payments, plus royalties. Opakalim is in Phase 2/3 trials, with results expected in late 2026. BHVN stock rose 5.12% to $14.38 on Tuesday and was up 7.93% in pre-market trading.

$STEPMedAI 9/10

StepStone Group Inc: StepStone Group Closes its Infrastructure Secondaries Fund, Raising $1.7 Billion Across the Fund and Related Separate Accounts

StepStone Group Inc. (STEP) closed its infrastructure secondaries fund, raising $1.7 billion. The fund, targeting infrastructure secondaries, surpassed its hard cap with $1.5 billion in commitments. StepStone, managing $245 billion in assets, focuses on private markets investments and advisory services.